This is a competing continuation application for the Cardiovascular Sciences Training Grant at the University of Chicago. The Iongterm goal of this program is to provide predoctoral and postdoctoral M.D. and Ph.D. trainees with outstanding training in cardiovascular biology using an interdepartmental and interdisciplinary. Established programs at the University of Chicago include cellular and molecular electrophysiology, mouse models of cardiovascular diseases, transplant biology and vascular biology. Human genetics of cardiovascular disease represents a newer component to our current program and includes training in single gene and complex trait disorders. We have faculty trainers from the Departments of Medicine (Sections of Cardiology, Nephrology, Endocrinology, Gastroenterology and Pulmonary Medicine), Human Genetics, Pediatrics, Biochemistry and Molecular Biology, and the Ben May Institute. Funding is requested for three predoctoral and six postdoctoral trainees per year. We have organized training into four groups: (i) Genetics of Cardiovascular Disease (ii) Cardiovascular Development (iii) Cellular and molecular Electrophysiology and (iv) Cardiovascular pathogenesis. Each of these groups has an emphasis on mammalian cardiovascular biology utilizing a variety of genetic and molecular approaches towards understanding normal and disease cardiovascular biology. This program historically has emphasized the training of M.D. fellows to establish these individuals as clinically-trained independent cardiovascular scientist and will provide at least three years of support for pre and postdoctoral fellows. With the availability of the human genome sequence and the era of rational, hypothesis driven translational research, we expect that basic science training for M.D. fellows will gain in its importance. Complementing this, we request continued support for predoctoral training positions since it is equally important to attract young trainees early in their career to cardiovascular sciences. The training program is directed by Elizabeth McNally, M.D., Ph.D. Dr. McNally is an Associate Professor who serves as the Director of Cardiovascular Research. Dr. Harry Fozzard will serve as a co-investigator. The training program will require individually tailed formal coursework, participation in a biweekly research seminar and journal club. Fellows are encouraged to attend one national meeting per year. Fellows will receive the majority of training in their preceptor's research laboratory. This program will serve to train individuals to become independent investigators in the problems of cardiovascular biology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007381-26
Application #
6775982
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Commarato, Michael
Project Start
1994-07-01
Project End
2009-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
26
Fiscal Year
2004
Total Cost
$462,007
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Steimle, Jeffrey D; Rankin, Scott A; Slagle, Christopher E et al. (2018) Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development. Proc Natl Acad Sci U S A 115:E10615-E10624
Duong, Tiffany B; Ravisankar, Padmapriyadarshini; Song, Yuntao Charlie et al. (2018) Nr2f1a balances atrial chamber and atrioventricular canal size via BMP signaling-independent and -dependent mechanisms. Dev Biol 434:7-14
Dai, Wenli; Weber, Christopher (2018) Tbx18 sets the pace. J Physiol 596:6129-6130
Laffin, Luke J; Bakris, George L (2018) Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension? Hypertension 72:836-838
Imamura, Teruhiko; Kim, Gene; Raikhelkar, Jayant et al. (2018) Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation. J Card Fail 24:575-582
Imamura, Teruhiko; Nguyen, Ann; Rodgers, Daniel et al. (2018) Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail 11:e005082
Laffin, Luke J; Hofmann-Bowman, Marion A (2018) Beyond Hypertension and Cardio-Renal Syndrome: The Need to Acknowledge and Incorporate Renal Disease in Cardiac Electrophysiology Trials. Am J Nephrol 48:32-35
Holzhauser, Luise; Nguyen, Ann; Jeevanandam, Valluvan et al. (2018) HeartNetâ„¢ in an explanted heart of a Jehovah's Witness. J Card Surg 33:765
Juricek, Colleen; Imamura, Teruhiko; Nguyen, Ann et al. (2018) Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail 24:249-254
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:

Showing the most recent 10 out of 164 publications